JP Morgan 2022: The Promise of Synthetic Biology
Let’s say you have used the OnyxTM Digital Genome Engineering platform to generate a library of hundreds, if not thousands, of edits that…
Ginkgo Bioworks Incorporates the Onyx® platform into its foundries
Let’s say you have used the OnyxTM Digital Genome Engineering platform to generate a library of hundreds, if not thousands, of edits that…
What Makes CRISPR Like a Movie Star? SynBioBeta podcast with Nandini Krishnamurthy
Let’s say you have used the OnyxTM Digital Genome Engineering platform to generate a library of hundreds, if not thousands, of edits that…
Inscripta Named Colorado Company of The Year
Let’s say you have used the OnyxTM Digital Genome Engineering platform to generate a library of hundreds, if not thousands, of edits that…
Inscripta’s MAD7™ CRISPR Nucleases Helping Hudson River Biosciences Improve Plant Editing
Let’s say you have used the OnyxTM Digital Genome Engineering platform to generate a library of hundreds, if not thousands, of edits that…
New Market Report Finds Near-Boundless Opportunity in Synthetic Biology
Let’s say you have used the OnyxTM Digital Genome Engineering platform to generate a library of hundreds, if not thousands, of edits that…
Inside Inscripta: Reem Baraka, Sequencing
Let’s say you have used the OnyxTM Digital Genome Engineering platform to generate a library of hundreds, if not thousands, of edits that…
Recap of SynBioBeta’s Chemicals & Materials Digital Conference
Let’s say you have used the OnyxTM Digital Genome Engineering platform to generate a library of hundreds, if not thousands, of edits that…
Webinar: Hypothesis-Driven and Empirical Approaches to Engineering Biology
Let’s say you have used the OnyxTM Digital Genome Engineering platform to generate a library of hundreds, if not thousands, of edits that…